Gallbladder Epithelial Cells, also known as cholangiocytes, constitute the lining of the gallbladder and bile ducts, playing a crucial role in bile production and transportation. These specialized cells are responsible for modifying and concentrating bile, a digestive fluid synthesized by the liver, which aids in the emulsification and absorption of fats. Cholangiocytes actively participate in the regulation of bile composition, electrolyte balance, and fluid secretion, ensuring optimal digestive function. They respond to hormonal signals and neural inputs, adjusting bile output according to dietary and physiological demands. Dysfunction of gallbladder epithelial cells can contribute to various gallbladder disorders, including cholelithiasis (gallstones) and cholecystitis (inflammation of the gallbladder). Moreover, cholangiocytes play a role in immune responses within the biliary system and are involved in tissue repair after injury. Research continues to explore the molecular mechanisms underlying the function of gallbladder epithelial cells, aiming to improve our understanding of bile homeostasis and develop targeted therapies for gallbladder-related disorders. This knowledge is integral to comprehending digestive physiology and advancing medical approaches to conditions affecting the biliary system.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy